-
Something wrong with this record ?
Lysosphingolipids in ceramide-deficient skin lipid models
G. Paraskevopoulos, L. Opálka, A. Kováčik, A. Paraskevopoulou, E. Panoutsopoulou, I. Sagrafena, P. Pullmannová, R. Čáp, K. Vávrová
Language English Country United States
Document type Journal Article
NLK
Directory of Open Access Journals
from 2021
Freely Accessible Science Journals
from 1959
PubMed Central
from 2008
Open Access Digital Library
from 1959-10-01
ROAD: Directory of Open Access Scholarly Resources
from 1959
- MeSH
- Models, Biological MeSH
- Ceramides * metabolism MeSH
- Phosphorylcholine analogs & derivatives MeSH
- Skin * metabolism MeSH
- Fatty Acids, Nonesterified metabolism MeSH
- Humans MeSH
- Lysophospholipids metabolism MeSH
- Permeability drug effects MeSH
- Sphingosine analogs & derivatives metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Ceramides are key components of the skin's permeability barrier. In atopic dermatitis, pathological hydrolysis of ceramide precursors - glucosylceramides and sphingomyelin - into lysosphingolipids, specifically glucosylsphingosine (GS) and sphingosine-phosphorylcholine (SPC), and free fatty acids (FFAs) has been proposed to contribute to impaired skin barrier function. This study investigated whether replacing ceramides with lysosphingolipids and FFAs in skin lipid barrier models would exacerbate barrier dysfunction. When applied topically to human stratum corneum sheets, SPC and GS increased water loss, decreased electrical impedance, and slightly disordered lipid chains. In lipid models containing isolated human stratum corneum ceramides, reducing ceramides by ≥ 30% significantly increased permeability to four markers, likely due to loss of long-periodicity phase (LPP) lamellae and phase separation within the lipid matrix, as revealed by X-ray diffraction and infrared spectroscopy. However, when the missing ceramides were replaced by lysosphingolipids and FFAs, no further increase in permeability was observed. Conversely, these molecules partially mitigated the negative effects of ceramide deficiency, particularly with 5%-10% SPC, which reduced permeability even compared to control with "healthy" lipid composition. These findings suggest that while ceramide deficiency is a key factor in skin barrier dysfunction, the presence of lysosphingolipids and FFAs does not aggravate lipid structural or functional damage, but may provide partial compensation, raising further questions about the behavior of lyso(sphingo)lipids in rigid multilamellar lipid environments, such as the stratum corneum, that warrant further investigation.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010446
- 003
- CZ-PrNML
- 005
- 20250429134710.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jlr.2024.100722 $2 doi
- 035 __
- $a (PubMed)39653083
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Paraskevopoulos, Georgios $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
- 245 10
- $a Lysosphingolipids in ceramide-deficient skin lipid models / $c G. Paraskevopoulos, L. Opálka, A. Kováčik, A. Paraskevopoulou, E. Panoutsopoulou, I. Sagrafena, P. Pullmannová, R. Čáp, K. Vávrová
- 520 9_
- $a Ceramides are key components of the skin's permeability barrier. In atopic dermatitis, pathological hydrolysis of ceramide precursors - glucosylceramides and sphingomyelin - into lysosphingolipids, specifically glucosylsphingosine (GS) and sphingosine-phosphorylcholine (SPC), and free fatty acids (FFAs) has been proposed to contribute to impaired skin barrier function. This study investigated whether replacing ceramides with lysosphingolipids and FFAs in skin lipid barrier models would exacerbate barrier dysfunction. When applied topically to human stratum corneum sheets, SPC and GS increased water loss, decreased electrical impedance, and slightly disordered lipid chains. In lipid models containing isolated human stratum corneum ceramides, reducing ceramides by ≥ 30% significantly increased permeability to four markers, likely due to loss of long-periodicity phase (LPP) lamellae and phase separation within the lipid matrix, as revealed by X-ray diffraction and infrared spectroscopy. However, when the missing ceramides were replaced by lysosphingolipids and FFAs, no further increase in permeability was observed. Conversely, these molecules partially mitigated the negative effects of ceramide deficiency, particularly with 5%-10% SPC, which reduced permeability even compared to control with "healthy" lipid composition. These findings suggest that while ceramide deficiency is a key factor in skin barrier dysfunction, the presence of lysosphingolipids and FFAs does not aggravate lipid structural or functional damage, but may provide partial compensation, raising further questions about the behavior of lyso(sphingo)lipids in rigid multilamellar lipid environments, such as the stratum corneum, that warrant further investigation.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a ceramidy $x metabolismus $7 D002518
- 650 12
- $a kůže $x metabolismus $7 D012867
- 650 _2
- $a sfingosin $x analogy a deriváty $x metabolismus $7 D013110
- 650 _2
- $a kyseliny mastné neesterifikované $x metabolismus $7 D005230
- 650 _2
- $a permeabilita $x účinky léků $7 D010539
- 650 _2
- $a lysofosfolipidy $x metabolismus $7 D008246
- 650 _2
- $a biologické modely $7 D008954
- 650 _2
- $a fosforylcholin $x analogy a deriváty $7 D010767
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Opálka, Lukáš $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Kováčik, Andrej $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Paraskevopoulou, Anna $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Panoutsopoulou, Eleni $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Sagrafena, Irene $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Pullmannová, Petra $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Čáp, Robert $u Plastic Surgery Clinic, Sanatorium Sanus, Hradec Králové, Czech Republic
- 700 1_
- $a Vávrová, Kateřina $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic. Electronic address: katerina.vavrova@faf.cuni.cz
- 773 0_
- $w MED00002766 $t Journal of lipid research $x 1539-7262 $g Roč. 66, č. 1 (2025), s. 100722
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39653083 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134705 $b ABA008
- 999 __
- $a ok $b bmc $g 2311665 $s 1247527
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 66 $c 1 $d 100722 $e 20241207 $i 1539-7262 $m Journal of lipid research $n J Lipid Res $x MED00002766
- LZP __
- $a Pubmed-20250415